Bright Minds Biosciences (DRUG) Shareholder's Equity (2022 - 2026)

Bright Minds Biosciences (DRUG) Shareholder's Equity (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 7.14 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 595,226.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 14.38 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 19.36 Bn
9 Abivax 90.15 Bn 90.15 Bn - 502.95 Mn
10 Bright Minds Biosciences 16.28 Bn 16.22 Bn - 266.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 266.73 Mn
Dec 31, 2025 98.08 Mn
Sep 30, 2025 89.56 Mn
Jun 30, 2025 64.89 Mn
Mar 31, 2025 62.65 Mn
Dec 31, 2024 63.72 Mn
Sep 30, 2024 25.97 Mn
Jun 30, 2024 25.62 Mn
Dec 31, 2023 25.74 Mn
Sep 30, 2023 4.92 Mn
Sep 30, 2022 8.08 Mn